Precision medicine is becoming increasingly important, creating more efficient personalised therapies for each patient and innovative pharmacological developments. In the oncology field, for example, researchers are developing different approaches aimed at directed and controlled drug release systems, thereby diminishing toxicity to the organism.
Click here for original story, Artificial ‘inclusion bodies’ created for controlled drug release
Source: Phys.org